Q61.19

Clinical Causes: Infantile polycystic kidney disease is caused by genetic mutations inherited in an autosomal recessive pattern. Specifically, it involves mutations of the PKHD1 gene, which encodes a protein called fibrocystin or polyductin. This protein plays a crucial role in the development and function of the kidneys and liver. When mutations occur, they lead to abnormal development of the renal tubules and cyst formation. The disorder is typically inherited from both parents, who are carriers of the defective gene, although they usually do not show symptoms. The main causes include: - Genetic mutations in the PKHD1 gene - Autosomal recessive inheritance pattern - No direct environmental causes attributed to the condition

Key Symptoms: Infantile polycystic kidney disease presents with several symptoms that develop in early childhood, often within the first few months of life. These symptoms can include: - Enlarged abdomen due to enlarged kidneys - Abdominal distension - Hypertension (high blood pressure) - Signs of kidney failure such as swelling, irritability, and poor feeding - Respiratory difficulties resulting from enlarged kidneys pressing on the lungs - Urinary issues, including blood in the urine or abnormal urine output - Liver cysts which may lead to hepatomegaly (enlarged liver) - Other systemic symptoms like growth delays in some cases

Diagnosis Path: Diagnosis of infantile polycystic kidney disease typically involves a combination of clinical evaluation, imaging, and genetic testing. Methods include: - Ultrasound imaging: Reveals enlarged kidneys with numerous cysts - Prenatal ultrasound: May detect kidney enlargement and cyst formation before birth - MRI or CT scans: For detailed visualization of cysts and kidney structure - Blood tests: To assess kidney function by measuring blood urea nitrogen (BUN) and creatinine levels - Urinalysis: To identify abnormalities such as proteinuria or hematuria - Genetic testing: Confirmatory test to identify mutations in the PKHD1 gene Early recognition through prenatal screening can facilitate prompt management and family planning discussions.

Treatment Protocols: There is no cure for infantile polycystic kidney disease; instead, management focuses on alleviating symptoms and preventing complications. Treatment strategies include: - Supportive care: Monitoring kidney function and managing symptoms - Blood pressure control: Using antihypertensive medications - Managing electrolyte imbalances and fluid intake - Treating associated conditions such as urinary tract infections - Dialysis: For children with advanced kidney failure to assist with waste removal - Kidney transplantation: In severe cases where kidney function deteriorates significantly - Addressing liver cysts and related complications as they arise A multidisciplinary team including pediatric nephrologists, genetic counselors, and other specialists usually coordinates care for affected children. Regular follow-up is critical for managing disease progression and improving quality of life.